Join to access to all OVN content. Join for Free
The ART of breaking out of your comfort zone
Introversion in MSL overcoming fear in medical science building a personal brand in healthcare networking for introverts success strategies for MSLs

The ART of breaking out of your comfort zone


Share This Article


Summary

In this episode, Cathy Andorfer joins Tom Caravela to discuss the unique challenges and advantages that introverts face within the medical science liaison (MSL) role. They explore the science behind introversion and extroversion, emphasizing the importance of overcoming fear and developing resilience. Cathy shares personal experiences and insights from her upcoming book, offering advice on goal setting, networking, and the significance of building a personal brand while staying authentic. The conversation wraps up with year-end reflections and the importance of being present in one's current role. The episode concludes with closing remarks, future episode teasers, and a reminder to subscribe.

Cathy Andorfer, US Field Medical Dermatology Lead at Bristol Myers Squibb discusses the art of breaking out of your comfort zone

Cathy shares…

👉 The difference between an introvert and an extrovert

👉 How introverts can find success in Medical Affairs

👉 Advice for extroverts on improved engagement

👉 Tips on how to do things that may terrify you

👉 Why “reflection” is so important and how to use it

Click for Source
Introversion in MSL, overcoming fear in medical science, building a personal brand in healthcare, networking for introverts, success strategies for MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Article
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures
OVN Avatar Forbes Books Press Release Official

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN